Your Messages Inbox
Your Article Summary
See Latest ArticlesNabi Biopharmaceuticals Announces Second Quarter 2009 Financial Results
Nabi Biopharmaceuticals, 08/07/09
Nabi Biopharmaceuticals announced its second quarter financial results for the three month period ended June 2009. The Company reported a net loss from continuing operations of $5.8 million, or $0.11 per share, compared to a net loss of $5.7 million, or $0.11 per share, for the period ended June 28, 2008. Including results from discontinued operations, Nabi had a net loss of $5.8 million, or $0.11 per share, for the current period compared to a net loss of $3.7 million, or $0.07 per share in the second quarter of 2008. The 2008 results have been adjusted to reflect the retrospective application of FSP 14–1 accounting rules for convertible debt instruments that were adopted in the first quarter of 2009.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
Genzyme, 12/07/09
Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09
Taro Provides Preliminary Third Quarter and Year-to-Date 2009 Financial Results
Taro Pharmaceuticals USA, 12/03/09
Article Search
Sponsor